Corbett Road Capital Management, LLC Halozyme Therapeutics, Inc. Transaction History
Corbett Road Capital Management, LLC
- $58.4 Million
- Q2 2022
A detailed history of Corbett Road Capital Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Corbett Road Capital Management, LLC holds 16,525 shares of HALO stock, worth $875,164. This represents 1.24% of its overall portfolio holdings.
Number of Shares
16,525Holding current value
$875,164% of portfolio
1.24%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$966 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$691 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$344 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$218 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$201 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.38B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...